New hope for older leukemia patients: gentler treatment trial seeks to control cancer
NCT ID NCT07153796
Summary
This study is testing whether a new drug called blinatumomab, given as an injection under the skin, works well and is safe when combined with lower-dose chemotherapy for older adults or those too frail for standard intensive chemotherapy who have a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). The main goals are to see if this combination helps patients live longer without their cancer returning and to monitor for any side effects. Researchers will enroll about 60 participants to gather this information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Texas M. D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.